DIO (KOSDAQ:A039840) - Share price, News & Analysis

A039840 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	5/6
Financial Health	4/6
Dividends	0/6

A039840 Stock Overview

DIO Corporation manufactures and sells dental implants in South Korea.

Rewards

Earnings are forecast to grow 23.39% per year

Earnings grew by 153.3% over the past year

Risk Analysis

No risks detected for A039840 from our risk checks.

DIO Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DIO
Historical stock prices
Current Share Price	₩31,700.00
52 Week High	₩55,000.00
52 Week Low	₩29,900.00
Beta	0.95
1 Month Change	-11.45%
3 Month Change	2.26%
1 Year Change	-16.03%
3 Year Change	-14.32%
5 Year Change	-12.79%
Change since IPO	736.41%

Shareholder Returns

	A039840	KR Medical Equipment	KR Market
7D	-2.8%	0.8%	1.2%
1Y	-16.0%	-4.7%	-14.3%

Return vs Industry: A039840 underperformed the KR Medical Equipment industry which returned -4.7% over the past year.

Return vs Market: A039840 underperformed the KR Market which returned -14.3% over the past year.

Price Volatility

Is A039840's price volatile compared to industry and market?
A039840 volatility
A039840 Average Weekly Movement	5.2%
Medical Equipment Industry Average Movement	5.6%
Market Average Movement	5.4%
10% most volatile stocks in KR Market	10.2%
10% least volatile stocks in KR Market	3.1%

Stable Share Price: A039840 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: A039840's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1988	480	Jin-Cheol Kim	https://www.dio.co.kr

DIO Corporation manufactures and sells dental implants in South Korea. It offers implant systems, which include UFII int. submerged and no-submerged systems, FTN external systems, protem mini systems, UV active and activators, and instrument kits.

DIO Fundamentals Summary

How do DIO's earnings and revenue compare to its market cap?
A039840 fundamental statistics
Market Cap	₩469.39b
Earnings (TTM)	₩28.25b
Revenue (TTM)	₩150.04b

16.6x

P/E Ratio

3.1x

P/S Ratio

Is A039840 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
A039840 income statement (TTM)
Revenue	₩150.04b
Cost of Revenue	₩42.49b
Gross Profit	₩107.55b
Other Expenses	₩79.30b
Earnings	₩28.25b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	1.91k
Gross Margin	71.68%
Net Profit Margin	18.83%
Debt/Equity Ratio	56.5%

How did A039840 perform over the long term?

See historical performance and comparison

Valuation

Is DIO undervalued compared to its fair value and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

16.61x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: A039840 (₩31700) is trading above our estimate of fair value (₩6107.38)

Significantly Below Fair Value: A039840 is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: A039840 is poor value based on its Price-To-Earnings Ratio (16.6x) compared to the KR Medical Equipment industry average (13.6x).

PE vs Market: A039840 is poor value based on its Price-To-Earnings Ratio (16.6x) compared to the KR market (14.1x).

Price to Earnings Growth Ratio

PEG Ratio: A039840 is good value based on its PEG Ratio (0.7x)

Price to Book Ratio

PB vs Industry: A039840's Price-To-Book Ratio (2.5x) is in line with the KR Medical Equipment industry average.

Future Growth

How is DIO forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

23.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A039840's forecast earnings growth (23.4% per year) is above the savings rate (3.5%).

Earnings vs Market: A039840's earnings (23.4% per year) are forecast to grow faster than the KR market (14.6% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A039840's revenue (19.5% per year) is forecast to grow faster than the KR market (9.6% per year).

High Growth Revenue: A039840's revenue (19.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A039840's Return on Equity is forecast to be low in 3 years time (19.3%).

Past Performance

How has DIO performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

7.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A039840 has high quality earnings.

Growing Profit Margin: A039840's current net profit margins (18.8%) are higher than last year (9.3%).

Past Earnings Growth Analysis

Earnings Trend: A039840's earnings have grown by 7.6% per year over the past 5 years.

Accelerating Growth: A039840's earnings growth over the past year (153.3%) exceeds its 5-year average (7.6% per year).

Earnings vs Industry: A039840 earnings growth over the past year (153.3%) exceeded the Medical Equipment industry 15.1%.

Return on Equity

High ROE: A039840's Return on Equity (15%) is considered low.

Financial Health

How is DIO's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: A039840's short term assets (₩201.2B) exceed its short term liabilities (₩140.5B).

Long Term Liabilities: A039840's short term assets (₩201.2B) exceed its long term liabilities (₩20.1B).

Debt to Equity History and Analysis

Debt Level: A039840's net debt to equity ratio (37.9%) is considered satisfactory.

Reducing Debt: A039840's debt to equity ratio has increased from 8.9% to 56.5% over the past 5 years.

Debt Coverage: A039840's debt is not well covered by operating cash flow (5.9%).

Interest Coverage: A039840's interest payments on its debt are well covered by EBIT (8.9x coverage).

Balance Sheet

Dividend

What is DIO current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate A039840's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A039840's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A039840's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A039840's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: A039840 is not paying a notable dividend for the KR market.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A039840 has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

CEO

Jin-Cheol Kim (69 yo)

no data

Tenure

Mr. Jin-Cheol Kim serves as Chairperson of the Board and Chief Executive Officer of DIO Corporation. Mr. Kim serves as Chief Executive Officer of Dong Seo Inc. He graduated at yungpook National University....

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/24 00:00
End of Day Share Price	2022/05/24 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31